[go: up one dir, main page]

GB2299025B - Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye - Google Patents

Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye

Info

Publication number
GB2299025B
GB2299025B GB9607420A GB9607420A GB2299025B GB 2299025 B GB2299025 B GB 2299025B GB 9607420 A GB9607420 A GB 9607420A GB 9607420 A GB9607420 A GB 9607420A GB 2299025 B GB2299025 B GB 2299025B
Authority
GB
United Kingdom
Prior art keywords
formulation
eye
treatment
fibrotic disorders
dispenser containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9607420A
Other versions
GB9607420D0 (en
GB2299025A (en
Inventor
Mark William James Ferguson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929205800A external-priority patent/GB9205800D0/en
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Priority to GB9607420A priority Critical patent/GB2299025B/en
Publication of GB9607420D0 publication Critical patent/GB9607420D0/en
Publication of GB2299025A publication Critical patent/GB2299025A/en
Application granted granted Critical
Publication of GB2299025B publication Critical patent/GB2299025B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9607420A 1992-03-17 1993-03-16 Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye Expired - Lifetime GB2299025B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9607420A GB2299025B (en) 1992-03-17 1993-03-16 Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929205800A GB9205800D0 (en) 1992-03-17 1992-03-17 Treatment of fibrotic disorders
GB9305344A GB2265310B (en) 1992-03-17 1993-03-16 Treatment of fibrotic disorders with mannose phosphates
GB9607420A GB2299025B (en) 1992-03-17 1993-03-16 Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye

Publications (3)

Publication Number Publication Date
GB9607420D0 GB9607420D0 (en) 1996-06-12
GB2299025A GB2299025A (en) 1996-09-25
GB2299025B true GB2299025B (en) 1996-11-27

Family

ID=26300547

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9607420A Expired - Lifetime GB2299025B (en) 1992-03-17 1993-03-16 Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye

Country Status (1)

Country Link
GB (1) GB2299025B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006503847A (en) 2002-09-27 2006-02-02 チルドレンズ メディカル センター コーポレーション Methods and compositions for the treatment of neurological diseases

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311956A (en) * 1969-10-02 1973-03-28 Merck & Co Inc Method of potentiating the activity of phosphonomycin antibiotics
JPS5058868A (en) * 1973-09-25 1975-05-21
WO1990001938A1 (en) * 1988-08-19 1990-03-08 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
WO1991009604A1 (en) * 1989-12-21 1991-07-11 Perstorp Ab A pharmaceutical composition comprising a phosphosugar

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311956A (en) * 1969-10-02 1973-03-28 Merck & Co Inc Method of potentiating the activity of phosphonomycin antibiotics
JPS5058868A (en) * 1973-09-25 1975-05-21
WO1990001938A1 (en) * 1988-08-19 1990-03-08 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
WO1991009604A1 (en) * 1989-12-21 1991-07-11 Perstorp Ab A pharmaceutical composition comprising a phosphosugar

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts 119:15132 & JP 50 058 868 A *

Also Published As

Publication number Publication date
GB9607420D0 (en) 1996-06-12
GB2299025A (en) 1996-09-25

Similar Documents

Publication Publication Date Title
AU3841193A (en) Facial tissue dispensing carton
GB9215276D0 (en) Liquid dispensers
GB9215275D0 (en) Liquid dispensers
AU116931S (en) Towel dispenser
EP0430431A3 (en) Atomizing fluid dispenser
AU121106S (en) Cosmetic dispenser
ZA936872B (en) 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-B]heterocyclic-2-one useful in the treatment of cognitive disorders of man
GB9216469D0 (en) Dispensers
PL302310A1 (en) Enamel applicator and dispensing plug therefor
GB9303157D0 (en) Treatment of a group of related disorders
GB2299025B (en) Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye
IL104755A0 (en) Treatment of glaucoma
AU116588S (en) Liquid dispenser
GB9225932D0 (en) Dispensers
GB2271559B (en) Dispensers
GB2275191B (en) Use of antifungal compounds in the treatment of skin disorders
GB2269367B (en) Dispensers
GB9201987D0 (en) Liquid dispenser
GB9206231D0 (en) Liquid dispenser
HU9402308D0 (en) Pharmaceutical compositions and their use for treating zinc deficient disorders
ZA935430B (en) 5 S penem derivatives their preparation and use
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
GB9306337D0 (en) Liquid dispenser
GB9223953D0 (en) Treatment of eye disorders
GB9224650D0 (en) Dispensers

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Expiry date: 20130315